Bone histomorphometry: A concise review for endocrinologists and clinicians;Histomorfometria óssea: Uma revisão concisa para endocrinologistas e clínicos

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 2, 2010, Pages 87-98

  Kulak, Carolina A Moreira ^a,b,c   Dempster, David W ^b,c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c HELEN HAYES HOSPITAL   (United States)

Author keywords

Bone biopsy; Bone histomorphometry; Bone structure; Metabolic bone diseases; Osteoporosis drugs

Indexed keywords

EID: 77952712630     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000200002     Document Type: Review

References (57)

1. Parfitt AM. The physiologic and clinical significance of bone histomorphometric data. In: Recker RR (ed.). Bone histomorphometry: techniques and interpretation. Boca Raton, FL: CRC Press, USA; 1983. p. 143-244.
2. Dempster DW, Shane ES. Bone quantification and dynamics of bone turnover by histomorphometric analysis In: Becker KL (ed.). Principles and practice of endocrinology and metabolism, 3rd ed. Lippincott Williams and Wilkins; 2001. p. 541-48.
3. Compston JE. Bone histomorphometry. In: Feldman D, Gloriex FH (eds.). Vitamin D. 2nd ed. Elsevier, Inc. 2005. p. 951-65.
4. Weinsten R. Clinical use of bone biopsy. In: Marcus R, Feldman D, Nelson D, Rosen CJ (eds). Osteoporosis. 3rd edition. Academic Press. 2008. p. 448-65.
5. Parfitt AM. Stereologic basis of bone histomorphometry; theory of quantitative microscopy and reconstruction of the third dimension. In: Recker RR (ed.). Bone histomorphometry: techniques and interpretation. Boca Raton, FL: CRC Press, USA; 1983. p. 53-85.
6. Malluche HM, Sherman D, Meyer W, Massry SG. A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tiss Int. 1982;34:439-44.
7. Frost HM. Preparation of thin undecalcified bone sections by rapid method. Stain Technol. 1958;33:273.
8. Frost HM. Tetracycline based analysis of bone dynamic. Calcif Tiss Res. 1969;3:211-37.
9. Dempster DW, Zhou H. New concepts in bone remodeling. In: Seibel MJ, Robins SP, Bilezikian JP (eds.). Dynamics of bone and cartilage metabolism: principles and clinical applications. 2nd ed. San Diego: Academic Press; 2006. p. 261-73.
10. Eriksen EF. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normal and in metabolic bone disease. Endocr Rev. 1986;7:378-408.
11. Rao DS, Matkovic V, Duncan H. Transiliac bone biopsy: complications and diagnostic value. Henry Ford Hosp Med. 1980;28:112-18.
12. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res. 1987;2:595-610.
13. Rauch F, Travers R, Glorieux FH. Cellular activity on the seven surfaces of iliac bone: a histomorphometric study in children and adolescents. J Bone Miner Res. 2006;21:513-9.
14. Lindsay R, Zhou H, Cosman F, Nieves J, Dempster DW, Hodsman AB. Effects of a one-month treatment with parathyroid hormone (1-34) on bone formation on cancellous, endocortical and periosteal surfaces of the human ilium. J Bone Miner Res. 2007;22(4):495-502.
15. Dempster DW, Ferguson-Pell MW, Mellish RWE, Cochran GVB, Xie F, Fey C, et al. Relationships between bone structure in the iliac crest and bone structure and strength in the lumbar spine. Osteoporosis Int. 1993;3:90-6.
16. Vedi S, Compston JE, Webb A, Tighe JR. Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects. Metab Bone Dis Relat Res. 1982;4(4):231-6.
17. Recker RR, Kimmel DB, Parfitt M, Davies M, Keshawarz N, Hinders S. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res. 1998;3:133-43.
18. Schnitzler CM, Pettifor JM, Mesquita JM, Bird MDT, Schnaid E, Smyth AE. Histomorphometry of iliac crest bone in 346 normal black and white South African adults. Bone Miner. 1990;10:183-99.
19. Parisien M, Cosman F, Morgan D, Schnitzer M, Liang X, Nieves J, et al. Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women. J Bone Miner Res. 1997;12(6):948-57.
20. Reis LM, Batalha JR, Munoz D, Borelli A, Correa PH, Carvalho AB, et al. Brazilian normal static bone histomorphometry: effects of age, sex, and race. J Bone Miner Metab. 2007;25:400-6.
21. Peach H, Compston JE, Vedi S, Horton LWL. The value of plasma calcium, phosphate and alkaline phosphatase in the diagnosis of histological osteomalacia. J Clin Pathol. 1982:35:625-30.
22. Siris ES, Clemens TL, Dempster DW, Shane E, Segre GV, Lindsay R, et al. Tumor induced osteomalacia. Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry. Am J Med. 1987;82:307-12.
23. Parfitt AM, Podenphant J, Villanueva AR, Frame B. Metabolic bone disease with and without osteomalacia after intestinal bypass: a bone histomorphometry study. Bone. 1985;6:211-20.
24. Arlot ME, Delmas PD, Chappard D, Meunier PJ. Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: comparison with normal postmenopausal women. Osteoporos Int. 1990:1:41-9.
25. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodeling in type I postmenopausal osteoporosis: quantitative assessment of rates of bone formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res. 1990;5:311.
26. Kimmel DB, Recker RR, Gallagher JC, Vaswani AS, Aloia JF. A comparison of iliac bone histomorphometry data in postmenopausal osteoporotic and normal subjects. Bone Miner. 1990:11:217-35.
27. Parisien M, Cosman F, Mellish RWE, Schnitzer M, Nieves J, Silverberg SJ, et al. Bone structure in postmenopausal hyperparathyroid, osteoporotic and normal women. J Bone Min Res. 1995;10:1393-9.
28. Eriksen EF, Mosekilde L, Melsen F. Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone. 1986;7:213-21.
29. Christiansen P, Steiniche T, Brockstedt H, et al. Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling and balance evaluated by histomorphometric methods. Bone. 1993;14:755-62
30. Dempster DW, Parisien M, Silverberg SJ, Liang X-G, Schnitzer M, Shen V, et al. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab. 1999;84:1562-6.
31. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med. 1999;107:561.
32. Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P. Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone. 1996;18(2):103-8.
33. Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr, et al. Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res. 2008;23(12):2018-24.
34. Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med. 1995;333:166-74.
35. Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69:1945-53.
36. Sherrard DJ, Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, et al. The spectrum of bone disease in end-stage renal failure: an evolving disorder. Kidney Int. 1993;43:436-42.
37. Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, et al. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int. 1993;44:860-6.
38. Miller PD. The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol. 2008;3:S140-50.
39. Vedi S, Compston JE. The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women. Bone. 1996;19(5):535-9.
40. Eriksen EF, Langdahl B, Vesterby A, Rungby J, Kassen M. Hormone replacement therapy prevents osteoclast hyperactivity: a histomorphometry study in early postmenopausal women. J Bone Miner Res. 1999;14(7):1217-21.
41. Vedi S, Purdie DW, Ballard P, Bord S, Cooper AC, Compston JE. Bone remodeling and structure in postmenopausal women treated with long-term, high dose estrogen therapy. Osteoporosis Int. 1999;10(1):52-8.
42. Khastgir G, Studd J, Holland J, Alaghband-Zadeh, Fox S, Chow J. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study. J Clin Endocrinol Metab. 2001;86(1):289-95.
43. Ott SM, Oleksis, Lu Y, Harper K, Lips P. Bone histomorphometry and biochemical marker results of 2 year placebo-controlled trial of raloxifene in postmenopausal women. J Bone Miner Res. 2002;17(2):341-8.
44. Weinstein RS, Parfitt AM, Marcus R, Greenwald M, Crans G, Muchmore DB. Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women. Osteoporosis Int. 2003;14(10):814-22.
45. Wright CD, Garrahan NJ, Stanton M, Gazet JC, Mansell SE, Compston JE. Effect of long term tamoxifen therapy on cancellous bone remodeling and structure in women with breast cancer. J Bone Miner Res. 1994;9(2):153-9.
46. Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Investigation. 1997;100(6):1475-80.
47. Chavassieux PM, Arlot ME, Roux JP, Portero N, Daifotis A, Yates AJ, et al. Effects of alendronate on bone quality and remodeling in glucocorticoid induced osteoporosis: a histomorphometry analysis of transiliac biopsies. J Bone Miner Res. 2000;15(4):754-62.
48. Eriksen EF, Melsen F, Sod E, Barton I, Chines A. Effects of long term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone. 2002;31(5):620-5.
49. Recker RR, Weinstein RS, Chesnut CH, Schimmer RC, Mahoney P, Hughes C, et al. Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study. Osteoporosis Int. 2004;15(3):231-7.
50. Recker RR, Ste-Marie LG, Langdahl B, Czerwinski E, Bonvoisin B, Masanauskaite D, et al. Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study. BONE. 2010;46(3):660-5. Epub 2009 Nov 10.
51. Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, Garcia-Hernandez PA, et al. Effect of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res. 2008;23:6-16.
52. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res. 2001;16(10):1846-53.
53. Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH (1-34) therapy in women with severe osteoporosis. Bone. 2000;27(2):311-8.
54. Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, et al. Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res. 2006;21:855-64.
55. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector JD, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Eng J Med. 2004;305(5):449-68.
56. Arlot M, Jiang Y, Genant HK, Zhao J, Burt-Pichat B, Roux JP, et al. Histomorphometric and μCT analysis of bone biopsies from postmenopausal women treated with strontium ranelate. J Bone Miner Res. 2008;23:215-22.
57. Recker RR, Marin F, Ish-Shalom S, Moricke R, Hawkins F, Kapetanos G, et al. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. J Bone Miner Res. 2009;24(8):1358-68.